Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study
CONCLUSION: Sacubitril/valsartan reduced the number of premature ventricular complexes and increased the percentage of biventricular pacing in a cohort of HFrEF patients already on optimal medical therapy. PVC reduction did not correlate with reverse left ventricular remodelling. Whether sacubitril/valsartan has any direct antiarrhythmic effects is an issue to be better explored in future studies.PMID:37467909 | DOI:10.1016/j.vph.2023.107196
Source: Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Mauro Acquaro Laura Scelsi Beatrice Pasotti Alessandro Seganti Marcello Spolverini Alessandra Greco Sandra Schirinzi Annalisa Turco Antonio Sanzo Simone Savastano Roberto Rordorf Stefano Ghio Source Type: research
More News: Arrhythmia | Cardiology | Diovan | Drugs & Pharmacology | Heart | Heart Failure | Heart Transplant | Italy Health | Statistics | Study | Transplant Surgery | Transplants | Ventricular Tachycardia